Todas las noticias

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), signed a Memorandum of Understanding for the acquisition of 100% of the capital – subject to conditions precedent being met – of Distimp, a European start-up with which the Group began exclusive negotiations last March.

Spineway announces that, on 28 April 2021, it filed its Universal Registration Document (“DEU”) for the 2020 financial year with the “Autorité des Marchés Financiers” (AMF – the French financial markets authority) under number R.21 - 012.

In accordance with Spineway’s forecasts, revenue for the first quarter of 2021 followed the trend of yearend 2020 and amounted to €0.9M (€1M for Q1 2020) as a result of the new public-health measures in place in the various countries in which Spineway operates. As a reminder, revenue for the first quarter is usually lower than that of other quarters due to the structure of the Group’s markets. Also, this figure does not yet show the effects of the Group’s various sales initiatives and developments that should bear fruit in the next two quarters

Spineway, specialized in the design of innovative surgical implants and instruments for the treatment of severe disorders of the spine, continues its international development with the organization of a workshop in Thailand on the use of its products, and the signature of a distribution agreement in the US state of Ohio.

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), announces that it has entered exclusive negotiations with a view to the acquisition of 100% of the capital of a European start-up specialized in the design, manufacture and sale of implants and instruments for spinal surgery.

The Combined General Meeting of Spineway’s shareholders was held upon first notice of meeting on Monday, 8 March 2020, behind closed doors, at the Company’s registered office. The number of shares held by the shareholders represented amounted to 3 232 993 768 shares, i.e., a turnout of 25.79%.

Spineway announces the signature of a partnership with the Italian company Tsunami Medical, pioneer in innovative 3D-printed solutions, for the sale of Twin Peaks interbody cages produced with 3D printers.

Spineway, specialized in the treatment of severe disorders of the spine, announces the first surgery in Thailand with Mont Blanc 3D+ instrumentation as well as the signature of an exclusive distribution agreement for the marketing of its products in Malaysia.

Spineway’s Board of Directors, at a meeting held on 25 January 2021 chaired by Stéphane Le Roux, closed the 2020 annual accounts.